Skip to main content
Premium Trial:

Request an Annual Quote

Wolfe Laboratories, BioMed Realty Trust, Grubb & Ellis, Tepha, The Beal Companies, DTZ FHO Partners, United BioSource, First Martin Corporation, Colliers International

Wolfe Laboratories Accommodates Growth with HQ Move to Watertown, Mass.
Wolfe Laboratories, a provider of preclinical contract research and development services to the pharmaceutical and biotechnology industries, will expand its corporate headquarters to accommodate rapid growth when it moves into larger space within Watertown, Mass.
Wolfe will move from 11,000 square feet at 313 Pleasant St. into more than 21,000 square feet it has agreed to lease at 134 Coolidge Ave., a two-story, 37,400-square-foot building owned by BioMed Realty Trust of San Diego. Two thirds of that space — about 14,000 square feet — will be used for laboratories, tripling the company’s lab space; the remainder, administrative offices and room for future expansion. The new headquarters is near Cambridge, Mass., and the Longwood medical area within Boston, where 21 medical and academic institutions are located.
Two Grubb & Ellis professionals — Hank Amabile, a senior vice president; and Ellie Fantini, a senior advisor — represented WLI in the lease transaction. Grubb & Ellis announced the deal on Aug. 15.

Tepha Relocates Company Headquarters to One Ledgemont Center in Lexington, Mass.
Tepha, the maker of the first biotech-derived, absorbable suture sold in the US, has moved into its new 20,000-square-foot corporate headquarters at One Ledgemont Center (99 Hayden Ave.) in Lexington, Mass. The company relocated from 840 Memorial Drive in Cambridge, Mass.
One Ledgemont Center is a 180,000-square-foot class A office building within the two-building, 380,000 square-foot Ledgemont Center campus, owned by The Beal Companies and located at routes 2 and 128. Ledgemont Center can accommodate office and laboratory users; its amenities include a full-service cafeteria, on-site management, covered parking, and shuttle service to MBTA’s Alewife station.
Tad Lee of Meredith & Grew represented Tepha, while Ledgemont Center was represented by its leasing team of John Boyle and Kim Roop of DTZ FHO Partners, which announced the deal on Aug. 15.

United BioSource Leases 10,920 Square Feet at Ann Arbor, Mich., Office
United BioSource, a Bethesda, Md.-based pharmaceutical services business, has signed a lease for 10,920 square feet of office space at 2200 Commonwealth Blvd. in Ann Arbor, Mich. UBC will occupy the first floor of the three-story, 33,000-square-foot building.
2200 Commonwealth Blvd. is located within the eight-building, 325,000-square-foot Plymouth Park, a 43-acre office/research-and-development campus on Ann Arbor's northeast side, one mile from the University of Michigan North Campus in Washtenaw County.
UBC develops products and services intended to demonstrate product effectiveness, manage safety, and document the value of innovative medicines in pharmaceuticals and biotechnology.
Tim Guest and Cameron McCausland of Colliers International represented UBC, while Michael Martin, an in-house principal, represented Plymouth Park owner First Martin Corporation.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.